Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .

Özgül, N; Köse, MEHMET; Keskin, HL; Turan, AT; Karalök, MA; Üreyen, I; Borani, N; Tulunay, HG

doi:10.3906/sag-1203-69

Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .

Özgül N., Köse M. F., Keskin H., Turan A., Karalök M., Üreyen I., ...More

Turkish journal of medical sciences, vol.44, pp.212-9, 2014 (SCI-Expanded, Scopus, TRDizin)

Publication Type: Article / Article
Volume: 44
Publication Date: 2014
Doi Number: 10.3906/sag-1203-69
Journal Name: Turkish journal of medical sciences
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.212-9
Keywords: Epithelial ovarian cancer, gynecological oncology, chemotherapy
Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Aim: To evaluate the effectiveness of the addition of epirubicin to conventional chemotherapy as a first-line therapy for stage III-IV epithelial ovarian cancer.